Karayağmurlu, AliKarayağmurlu, ElifÜstündağ, Mehmet FatihYazla Asaf, Ece2019-05-132019-05-132018Karayağmurlu, A., Karayağmurlu, E., Üstündağ, M. F., Yazla, E. (2018). A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride. Electronic Journal of General Medicine, 15(3).2516-3507https://doi.org/10.29333/ejgm/83617https://hdl.handle.net/11491/1919Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature. © 2018 by the authors; licensee Modestum Ltd., UK.enAttribution 4.0 International (CC BY 4.0)info:eu-repo/semantics/openAccessAmisulprideAtypical AntipsychoticsElectroconvulsive TherapyNeuroleptic Malignant SyndromeArticle15310.29333/ejgm/83617N/AQ1